Viatris (VTRS) Gross Margin Growth (1y) (2021 - 2026)
Viatris (VTRS) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -712.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 156.00 |
| Mar 31, 2026 | -271.00 |
| Dec 31, 2025 | -421.00 |
| Sep 30, 2025 | -242.00 |
| Jun 30, 2025 | -83.00 |
| Mar 31, 2025 | -537.00 |
| Dec 31, 2024 | -713.00 |
| Sep 30, 2024 | -409.00 |
| Jun 30, 2024 | -287.00 |
| Mar 31, 2024 | -30.00 |
| Dec 31, 2023 | 945.00 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | -44.00 |
| Mar 31, 2023 | -104.00 |
| Dec 31, 2022 | -254.00 |
| Sep 30, 2022 | 816.00 |
| Jun 30, 2022 | 1,238.00 |
| Mar 31, 2022 | 1,677.00 |
| Dec 31, 2021 | 1,562.00 |
| Mar 31, 2021 | -939.00 |